CD40LG and pachyonychia congenita: In this regard, the soluble form of CD40 ligand (sCD40L), whose serum concentrations have demonstrated prognostic value in PC patients [25], has been implicated in inflammation, angiogenesis, and immune suppression, among other tumor processes, via its CD40 receptor [26–28].